ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LIVN Livanova

50.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Livanova LSE:LIVN London Ordinary Share GB00BYMT0J19 ORD GBP1.00 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 50.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

LivaNova PLC Livanova Plc: Transaction In Own Shares

18/10/2016 7:00am

UK Regulatory


 
TIDMLIVN 
 
 
 
   LONDON, Oct. 18, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (the "Company" or 
"LivaNova") announces on 18 October 2016, the repurchase of 11,200 
ordinary shares on 17 October 2016 as a part of the US $150 million 
share repurchase programme previously announced on 2 August 2016.  The 
highest price paid per ordinary share was $56.97 and the lowest price 
paid per share was $56.48.  The repurchased shares will be cancelled. 
As of 17 October 2016, after giving effect to the cancellation of these 
ordinary shares, the number of shares of ordinary shares outstanding 
would be 48,814,221, and the total number of voting rights in the 
Company would be 48,814,221, which may be used by shareholders as the 
denominator for the calculations by which they will determine if they 
are required to notify their interest in, or a change to their interest 
in the Company under the FCA's Disclosure Guidance and Transparency 
Rules. 
 
   The above purchases were made by Merrill Lynch, Pierce, Fenner & Smith 
Incorporated. 
 
   About LivaNova 
 
   LivaNova PLC is a global medical technology company formed by the merger 
of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, 
and Cyberonics Inc., a medical device company with core expertise in 
neuromodulation.  LivaNova transforms medical innovation into meaningful 
solutions for the benefit of patients, healthcare professionals, and 
healthcare systems.  The Company employs approximately 4,600 employees 
worldwide and is headquartered in London, U.K.  With a presence in more 
than 100 countries, LivaNova operates as three business units: Cardiac 
Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating 
headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), 
respectively. 
 
   LivaNova is listed on NASDAQ and listed on the Official List of the UK's 
Financial Conduct Authority and traded on London Stock Exchange (LSE) 
under the ticker symbol "LIVN". 
 
   For more information, please visit www.livanova.com, or contact: 
 
   Investor Relations and Media 
 
   Karen King 
 
   Vice President, Investor Relations & Corporate Communications 
 
   Phone: +1 (281) 228-7262 
 
   Fax: +1 (281) 218-9332 
 
   e-mail: corporate.communications@livanova.com 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: LivaNova PLC via Globenewswire 
 
 
 
 

(END) Dow Jones Newswires

October 18, 2016 02:00 ET (06:00 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.

1 Year Livanova Chart

1 Year Livanova Chart

1 Month Livanova Chart

1 Month Livanova Chart

Your Recent History

Delayed Upgrade Clock